| Literature DB >> 28486434 |
Taha Soliman Gamal1, Abd-Allah Sayed Madiha2, Mostafa Kamel Hanan3, Mohamed El-Mazary Abdel-Azeem4, Gamil S Marian5.
Abstract
Vitamin D is a fat-soluble vitamin that is important for calcium metabolism and plays an important role in the immune functions. The aim of this study was to measure neonatal and maternal 25-OH vitamin D serum levels in neonates with early onset sepsis. The study included fifty neonates with early onset sepsis (25 full-term and 25 preterm infants) and thirty age and sex matched healthy neonates as controls. After history taking and clinical examination, complete blood count, C-reactive protein and 25-OH vitamin D serum levels (neonatal and maternal) were measured for all neonates. The mean gestational age for neonates with sepsis was (37.5 ± 0.98 for full term and 34.1 ± 1.26 for preterm neonates). Neonatal and maternal 25-OH vitamin D serum levels were significantly lower in patients (6.4 ± 1.8 and 24.6 ± 2.2 nmol/L) than controls (42.5 ± 20.7 and 50.4 ± 21.4 nmol/L). Significant negative correlations between neonatal and maternal 25-OH vitamin D serum levels and all sepsis markers and significant positive correlations between neonatal and maternal 25-OH vitamin D levels were present. At cut-off values <20 nmol/L for neonatal and <42 nmol/L for maternal 25-OH vitamin D for detection of neonatal sepsis, the sensitivity, specificity, positive predicted value (PPV) and negative predicted value (NPV) were 84%, 79%, 94.7% and 82.3% for neonatal and 82%, 77%, 91.4% and 80.6% for maternal 25-OH vitamin D, respectively. Positive correlations between neonatal and maternal 25-OH Vitamin D serum levels are present and they are negatively correlated with all sepsis markers. They can be sensitive early predictors for early onset sepsis in neonates.Entities:
Keywords: 25-OH vitamin D; early onset; neonatal; sepsis; serum
Year: 2017 PMID: 28486434 PMCID: PMC5447995 DOI: 10.3390/children4050037
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Demographic data of studied neonates.
| Item | Full-term ( | Preterm ( | |||||
|---|---|---|---|---|---|---|---|
| Patients | Control | Patients | Control | ||||
| Gestational age (weeks) | Mean ± SD | 37.5 ± 0.98 | 37.4 ± 0.58 | 0.08 | 34.1 ± 1.26 | 35.2 ± 2.14 | 0.15 |
| Birth weight (kg) | Mean ± SD | 3.2 ± 0.43 | 3.19 ± 0.35 | 0.08 | 2.78 ± 0.3 | 2.14 ± 0.26 | 0.06 |
| Gender | Male | 14 (56%) | 12 (80%) | 0.19 | 15 (60%) | 8 (53%) | 0.63 |
| Mode of delivery | NVD | 17 (68%) | 12 (80%) | 0.54 | 7 (28%) | 3 (20%) | 0.66 |
| Maternal risk factors | Yes | 13 (52%) | 3 (20%) | 0.04 | 14 (56%) | 13 (86.6%) | 0.04 |
SD: standard deviation; NVD: normal vaginal delivery; CS: caesarean section.
Some laboratory data of studied neonates.
| Item | Patients ( | Controls ( | |
|---|---|---|---|
| Hb (gm/dL) | 12.9 ± 3.4 | 15.4 ± 2.2 | 0.04 |
| WBCs (×10³/µL) | 20,038 ± 18,237.4 | 10,304 ± 3201.6 | 0.003 |
| Platelets (×10³/µL) | 89 ± 8.4 | 255 ± 5.9 | 0.002 |
| Neutrophils(×10³/µL) | 63.2 ± 12.9 | 37.5 ± 7.7 | 0.001 |
| Staff (×10³/µL) | 11.8 ± 7.4 | 3.0 ± 1.2 | 0.004 |
| Segmented(×10³/µL) | 51.9 ± 11.9 | 34.4 ± 7.5 | 0.01 |
| ANC | 11,184.5 ± 75.7 | 3847.2 ± 13.7 | 0.001 |
| I/T ratio | 0.2 ± 0.1 | 0.1 ± 0.03 | 0.01 |
| CRP (mg/L) | 37.6 ± 9.02 | 6.0 ± 1.05 | 0.001 |
| IL-6 (pg/mL) | 139.9 ± 70.19 | 5.8 ± 3.8 | 0.001 |
| Neonatal. 25-OH Vit.D (nmol/L) | 6.4 ± 1.8 | 24.6 ± 2.2 | 0.001 |
| Maternal. 25-OH Vit.D (nmol/L) | 42.5 ± 20.7 | 50.4 ± 21.4 | 0.01 |
Hb: hemoglobin; WBCs: white blood cells; ANC: Absolute Neutrophil Count; I/T ratio: immature/total neutrophils ratio; CRP: C-reactive protein; IL-6: interleukin 6.
Figure 1Correlation between 25-OH vitamin D serum level and immature/ total neutrophils ratio (I/T ratio).
Figure 2Correlation between 25-OH vitamin D serum level and C-reactive protein (CRP) levels.